Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs). EJSO 2017; 43: 1550-1558.

Published: 17th May 2018

Authors: Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Nowak K, Kieser M et al.


The study included four randomized trials consisting of 553 patients. Survival was determined by the same factors in those who had chemotherapy as those who had surgery alone: tumour stage and completeness of resection.

Pubmed Link

Your comments